Relmada Therapeutics
RLMD
#8408
Rank
NZ$0.51 B
Marketcap
NZ$4.79
Share price
-15.76%
Change (1 day)
-37.02%
Change (1 year)

EPS for Relmada Therapeutics (RLMD)

EPS in 2026 (TTM): NZ-$1.59

According to Relmada Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$1.70. In 2025 the company made an earnings per share (EPS) of NZ-$2.65 an increase over its 2024 EPS that were of NZ-$4.84.

EPS history for Relmada Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.59-40.16%
2025NZ-$2.65-45.28%
2024NZ-$4.84-19.21%
2023NZ-$6.00-38.11%
2022NZ-$9.69-25.98%
2021NZ-$13.0987.93%
2020NZ-$6.9639.05%
2019NZ-$5.01-4.2%
2018NZ-$5.2337.5%
2017NZ-$3.80100%
2016NZ-$1.90-87.56%
2015NZ-$15.28
2013NZ-$0.05774273.48%
2012NZ-$0.01546

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cytokinetics
CYTK
NZ-$11.04 549.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.23-231.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel